A prospective study of steroid maintenance therapy in angioimmunoblastic T cell lymphoma
Phase 2
- Conditions
- Angioimmunoblastic T cell lymphoma
- Registration Number
- JPRN-UMIN000010338
- Lead Sponsor
- Division of Hematology, Department of Internal Medicine, Keio University of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 22
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with active malignancy other than lymphoma Patients positive for HBs-Ag, HCV-Ab, HIV-Ab, HTLV-1-Ab Patients with active tuberculosis infection Patients that require antibiotecs therapy for infection
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method